The prognosis of patients with nasopharyngeal cancer combined with liver metastasis is poor, and some studies claim that the 5-year overall survival rate after treatment is about 10%~15%, which varies from person to person.
Nasopharyngeal cancer is a malignant tumor that occurs in the mucosa of nasopharynx. The cause of the disease is not clear, some studies say it is related to EBV infection, chemical factors, genetic factors and so on. Nasopharyngeal cancer grows in the nasopharynx at the back of the nasal cavity and its location is relatively hidden. It often has no obvious symptoms in early stage and is easy to be neglected.
NPC is one of the most common malignant tumors in the southern region of China, more than 95% of which are low-differentiated carcinomas with high malignant degree, rapid growth and easy to develop distant metastasis. Research shows that 6%~15% of patients have distant metastasis at the first diagnosis, among which bone, lung and liver are the most common metastatic organs.
The prognosis of nasopharyngeal cancer combined with liver metastasis is closely related to age, treatment and whether there are other organ metastases. According to a study in China, the overall survival rate of patients with nasopharyngeal cancer combined with liver metastasis in 1 and 2 years is 54.8% and 14.6% respectively, and the median survival time is 10 months. There are also studies that the 5-year overall survival rate after treatment is about 10%~15%.
If nasopharyngeal cancer is combined with liver metastasis, it is recommended to go to regular hospitals for comprehensive evaluation of the condition and clear diagnosis, and if there is any abnormality, it is necessary to follow the doctor’s instructions and cooperate with the treatment in order to avoid delaying the condition.